IMV Inc IMVIF

IMV featured in Inkresearch

[Investtowin99]

Morning INK :: Unanimous insider buying at IMV (IMV) From June 15th to September 21st, IMV (IMV) Director Albert Scardino acquired a total of 22,200 common shares on a direct ownership basis at an average price of US$5.03. In addition, on June 21st, Mr. Scardino acquired a total of 3,200 common shares on a direct ownership basis at an average price of $6.39. Mr. Scardino is the largest insider equity holder at the company with 4.11% of shares outstanding. In addition, from June 8th to September 20th, Chairman of the Board Andrew Sheldon acquired a total of 10,500 common shares on a direct ownership basis at an average price of $7.23. Mr. Sheldon is the fifth largest insider equity holder at the company with 0.16% of shares outstanding. From June 19th to July 27th, Director Alfred Smithers acquired a total of 27,950 common shares at an average price of $6.68. Mr. Smithers is the second largest insider equity holder at the company with 2.91% of shares outstanding. On June 20th, CEO Frederic Ors acquired 375 common shares at a price of $6.92. Mr. Ors is the third largest insider equity holder at the company with 0.29% of shares outstanding. Finally, on June 6th, CFO Pierre Labbe (OR,OSK,etc.) acquired 600 common shares on a direct ownership basis at a price of $8.07. Mr. Labbe is the fourth largest insider equity holder at the company with 0.22% of shares outstanding. IMV has above median ownership (direct & indirect holdings) by Officers and Directors compared to other small-cap stocks in the Healthcare sector according to SEDI filings as of October 13th, 2018. IMV currently holds a sunny INK Edge outlook on the equally weighted V.I.P. criteria of valuations, insider commitment and price momentum which places it in the top 10% of all stocks ranked.